Pentwater Capital Management LP Sutro Biopharma, Inc. Transaction History

Pentwater Capital Management LP

$9.58 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$2.07 - $4.54 $41,400 - $90,800	20,000 Added 4.65%	450,000 $1.93 Million
Q3 2023 Nov 14, 2023	BUY	$3.29 - $4.9 $98,700 - $147,000	30,000 Added 7.5%	430,000 $1.49 Million
Q2 2023 Aug 14, 2023	BUY	$4.25 - $5.88 $616,250 - $852,600	145,000 Added 56.86%	400,000 $1.86 Million
Q1 2023 May 15, 2023	BUY	$4.48 - $8.45 $134,400 - $253,499	30,000 Added 13.33%	255,000 $1.18 Million
Q4 2022 Feb 14, 2023	SELL	$5.41 - $8.08 $730,350 - $1.09 Million	-135,000 Reduced 37.5%	225,000 $1.82 Million
Q3 2022 Nov 14, 2022	SELL	$5.17 - $7.11 $103,400 - $142,200	-20,000 Reduced 5.26%	360,000 $2 Million
Q2 2022 Aug 15, 2022	BUY	$3.41 - $8.95 $443,300 - $1.16 Million	130,000 Added 52.0%	380,000 $1.98 Million
Q1 2022 May 16, 2022	BUY	$7.78 - $15.31 $155,600 - $306,200	20,000 Added 8.7%	250,000 $2.06 Million
Q4 2021 Feb 11, 2022	BUY	$14.25 - $23.53 $285,000 - $470,600	20,000 Added 9.52%	230,000 $3.42 Million
Q2 2021 Aug 16, 2021	BUY	$18.03 - $23.82 $459,746 - $607,386	25,499 Added 13.82%	210,000 $3.9 Million
Q1 2021 May 17, 2021	SELL	$20.29 - $27.54 $2.03 Million - $2.75 Million	-100,000 Reduced 35.15%	184,501 $4.2 Million
Q4 2020 Feb 16, 2021	SELL	$10.16 - $23.98 $919,469 - $2.17 Million	-90,499 Reduced 24.13%	284,501 $6.18 Million
Q3 2020 Nov 16, 2020	SELL	$7.44 - $13.15 $52,273 - $92,391	-7,026 Reduced 1.84%	375,000 $3.77 Million
Q2 2020 Aug 14, 2020	BUY	$7.24 - $11.05 $2.23 Million - $3.4 Million	307,641 Added 413.58%	382,026 $2.97 Million
Q1 2020 May 15, 2020	SELL	$6.19 - $12.16 $34,088 - $66,965	-5,507 Reduced 6.89%	74,385 $759,000
Q4 2019 Feb 14, 2020	SELL	$8.15 - $11.39 $74,890 - $104,662	-9,189 Reduced 10.32%	79,892 $879,000
Q3 2019 Nov 14, 2019	SELL	$7.91 - $11.76 $86,369 - $128,407	-10,919 Reduced 10.92%	89,081 $810,000
Q2 2019 Aug 14, 2019	SELL	$9.69 - $12.23 $261,678 - $330,271	-27,005 Reduced 21.26%	100,000 $1.14 Million
Q1 2019 May 15, 2019	BUY	$8.8 - $11.87 $221,733 - $299,088	25,197 Added 24.75%	127,005 $1.45 Million
Q4 2018 Feb 14, 2019	BUY	$8.69 - $14.85 $276,411 - $472,348	31,808 Added 45.44%	101,808 $918,000
Q3 2018 Nov 14, 2018	BUY	$15.0 - $15.2 $1.05 Million - $1.06 Million	70,000 New	70,000 $1.05 Million

Others Institutions Holding STRO

# of Institutions

136

Shares Held

62.4M

Call Options Held

77.1K

Put Options Held

31.4K

Suvretta Capital Management, LLC New York, NY

7.19M
Shares

$19.2 Million
0.98% of portfolio
Black Rock Inc. New York, NY

6.91M
Shares

$18.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.2M
Shares

$11.2 Million
0.0% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

3M
Shares

$8 Million
0.03% of portfolio
Bio Impact Capital LLC Cambridge, MA

2.83M
Shares

$7.56 Million
1.53% of portfolio

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $139M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Pentwater Capital Management LP with notifications on news.

Account